1Dept. of Otolaryngology, Hokkaido University School of Medicine, Sapporo, Japan.
This study explores second-line chemotherapy for recurrent head and neck cancer. Research focused on drug resistance and novel combinations to improve treatment options after initial cisplatin-based therapies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: